Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Bodyflight BODY Jan 17, 2020 3.50 0.00   
 Boliden BOL Jan 17, 2020 263.30 +2.69   
 Bonava A BONAVA Jan 17, 2020 105.50 +1.93   
 Bonava B BONAVB Jan 17, 2020 103.50 +2.17   
 BONESUPPORT BONEX Jan 17, 2020 38.60 0.00   
 Bong BONG Jan 17, 2020 0.82 +0.74   
 Bonheur BONO Jan 17, 2020 216.00 +4.35   
 Bonäsudden Holding BONAS Jan 17, 2020 175.00 -1.69   
 Boozt BOOZT Jan 17, 2020 50.60 -2.69   
 Borr Drilling BDRILLO Jan 17, 2020 71.00 -1.39   
 Borregaard BRGO Jan 17, 2020 91.90 0.00   
 Bosjö Fastigheter BOSJO Jan 17, 2020 150.00 +1.35   
 Botnia Exploration Holding BOTX Jan 17, 2020 4.00 0.00   
 Boule Diagnostics BOUL Jan 17, 2020 75.50 +1.34   
 Bouvet BOUVETO Jan 17, 2020 386.00 0.00   
 BrainCool BRAIN Jan 17, 2020 6.19 +0.81   
 BrandBee BRANDB Jan 17, 2020 0.07 -9.46   
 Bravida Holding BRAV Jan 17, 2020 88.00 +0.06   
 Bredband2 BRE2 Jan 17, 2020 1.31 0.00   
 Brighter BRIG Jan 17, 2020 5.84 +1.04   
 Brinova Fastigheter AB ser. B BRINB Jan 17, 2020 32.80 -1.80   
 Briox BRIX Jan 17, 2020 11.30 0.00   
 Bråviken BRALOG Jan 17, 2020 127.00 -0.78   
 BTS Group B BTSB Jan 17, 2020 257.00 -0.39   
 Bublar Group BUBL Jan 17, 2020 5.20 +0.19   
 Bufab BUFAB Jan 17, 2020 130.80 -2.53   
 Bulten BULTEN Jan 17, 2020 74.30 -0.67   
 Bure Equity BURE Jan 17, 2020 220.00 +0.23   
 BW LPG BWLPGO Jan 17, 2020 73.85 +0.82   
 BW Offshore Limited BWOO Jan 17, 2020 65.05 +1.64   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK